Influence of chronic use of corticosteroids and calcineurin inhibitors on COVID-19 clinical outcomes: analysis of a nationwide registry
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Influence of chronic use of corticosteroids and calcineurin inhibitors on COVID-19 clinical outcomes: analysis of a nationwide registry
Authors
Keywords
COVID-19, immunocompromised host, prognosis factors, solid organ transplantation, autoimmune diseases, immune-mediated inflammatory diseases
Journal
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Volume 116, Issue -, Pages 51-58
Publisher
Elsevier BV
Online
2021-12-29
DOI
10.1016/j.ijid.2021.12.327
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Importance of Understanding the Stages of COVID-19 in Treatment and Trials
- (2021) Daniel O. Griffin et al. AIDS REVIEWS
- Tacrolimus use and COVID-19 infection in patients after solid organ transplantation
- (2021) Saifu Yin et al. GASTROENTEROLOGY
- COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients
- (2021) Jennifer A. Belsky et al. JOURNAL OF INFECTION
- The time to offer treatments for COVID-19
- (2021) Binh T. Ngo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Autoimmune Diseases and COVID-19 as Risk Factors for Poor Outcomes: Data on 13,940 Hospitalized Patients from the Spanish Nationwide SEMI-COVID-19 Registry
- (2021) María Ayala Gutiérrez et al. Journal of Clinical Medicine
- Incidence, Clinical Presentation, Relapses and Outcome of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Patients Treated With Anti-CD20 Monoclonal Antibodies
- (2021) Jorge Calderón-Parra et al. CLINICAL INFECTIOUS DISEASES
- The effect of immunosuppressants on the prognosis of SARS-CoV-2 infection
- (2021) Daniel Ward et al. EUROPEAN RESPIRATORY JOURNAL
- In-hospital mortality among immunosuppressed patients with COVID-19: Analysis from a national cohort in Spain
- (2021) Inés Suárez-García et al. PLoS One
- Severe Lymphopenia as a Predictor of COVID-19 Mortality in Immunosuppressed Patients
- (2021) María Martínez-Urbistondo et al. Journal of Clinical Medicine
- An interactive web-based dashboard to track COVID-19 in real time
- (2020) Ensheng Dong et al. LANCET INFECTIOUS DISEASES
- COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster
- (2020) Yuanyuan Han et al. CLINICAL IMMUNOLOGY
- How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review
- (2020) Chiara Minotti et al. JOURNAL OF INFECTION
- Glucocorticoid therapy delays the clearance of SARS‐CoV‐2 RNA in an asymptomatic COVID‐19 patient
- (2020) Shu‐Qing Ma et al. JOURNAL OF MEDICAL VIROLOGY
- Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic
- (2020) Lorenzo D’Antiga LIVER TRANSPLANTATION
- Cyclosporine and COVID‐19: Risk or Favorable?
- (2020) Nadia Nicholine Poulsen et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study
- (2020) Jose L Pablos et al. ANNALS OF THE RHEUMATIC DISEASES
- Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab
- (2020) Hendrik Schulze-Koops et al. ANNALS OF THE RHEUMATIC DISEASES
- The Right Time for Steroids in COVID-19
- (2020) Ana Fernández-Cruz et al. CLINICAL INFECTIOUS DISEASES
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
- (2020) Jesús Rodríguez-Baño et al. CLINICAL MICROBIOLOGY AND INFECTION
- COVID-19 in patients with inflammatory bowel disease
- (2020) Shrihari Anil Anikhindi et al. Expert Review of Gastroenterology & Hepatology
- Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform
- (2020) Anna Schultze et al. Lancet Respiratory Medicine
- Efficacy Evaluation of Early, Low-Dose, Short-Term Corticosteroids in Adults Hospitalized with Non-Severe COVID-19 Pneumonia: A Retrospective Cohort Study
- (2020) Qiang Li et al. Infectious Diseases and Therapy
- Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients
- (2020) ANNALS OF THE RHEUMATIC DISEASES
- Protective role of tacrolimus, deleterious role of age and comorbidities in liver transplant recipients with Covid-19: results from the ELITA/ELTR multi-center European study
- (2020) Luca S. Belli et al. GASTROENTEROLOGY
- Cyclosporine A plus low‐dose steroid treatment in COVID‐19 improves clinical outcomes in patients with moderate to severe disease. A pilot study
- (2020) Jose Luis Galvez‐Romero et al. JOURNAL OF INTERNAL MEDICINE
- Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication
- (2019) Yue Ma-Lauer et al. ANTIVIRAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started